Australia’s vaccine advisers used their 2025 annual statement to highlight stubbornly low influenza uptake among young children, with only 21.1 per cent of kids aged six months to under five years receiving at least one dose by 30 June 2024.

Why under-fives matter

The Australian Technical Advisory Group on Immunisation notes that healthy children in the five-to-15 age band are not all eligible for National Immunisation Program-funded flu shots, yet toddlers and preschoolers hospitalise at higher rates when H3N2 or influenza B circulate in childcare centres. Coverage for Aboriginal and Torres Strait Islander children in the under-five cohort was just 14.1 per cent at the same midpoint, well below national targets.

GPs and paediatric nurses remain the most trusted messengers, but appointment backlogs after winter respiratory surges mean many families defer shots until fever season is already underway. ATAGI reiterates that vaccination can continue while viruses circulate if stock with valid expiry dates remains available.

Programme changes on the horizon

The statement flags work on transitioning from quadrivalent to trivalent influenza vaccines globally after the disappearance of the B/Yamagata lineage. The Therapeutic Goods Administration’s Australian Influenza Vaccine Committee recommended 2026 southern hemisphere strains in October, swapping two components compared with 2025.

For parents booking now, the 2025 formulations still matter: adults 65 and older should receive adjuvanted or high-dose products, while most younger adults use standard quadrivalent shots listed on the PBS.

State clinic pressures

Victoria and New South Wales syndromic surveillance networks reported rising influenza-like illness presentations in September, prompting some pharmacies to restock private-market doses. Public health units emphasise co-administration with COVID boosters where eligible, reducing separate visit friction.

Childcare operators are updating exclusion policies to match national guidelines, but they cannot compensate for low community immunity. Employers who grant paid leave for parents to vaccinate kids see fewer cascading absences when centres hit outbreak thresholds.

Practical advice for families

ATAGI’s March influenza statement recommended booking before peak season when possible, while acknowledging that late shots still benefit travellers heading to the northern hemisphere winter. Parents should bring Medicare cards, ask specifically for age-appropriate doses, and report adverse events through standard TGA channels.

The headline percentage—barely one in five under-fives protected—is not a bureaucratic footnote; it is a measure of how much work remains before the next childcare cough turns into a paediatric ward admission.

Pharmacy and workplace angles

Community pharmacies participating in state-funded programs report uneven stock after wholesalers prioritised hospital orders. ATAGI encourages pharmacists to record vaccinations in the Australian Immunisation Register even when doses are privately paid, so public health units can see postcode-level gaps.

Large employers with on-site clinics are offering family vaccination days; uptake jumps when paid leave covers both parents. Without that flexibility, shift workers miss short appointment windows and defer shots until illness forces the issue.